Lepu Medical Tech Beijing
Lepu Medical Technology (Beijing) Co., Ltd. develops, manufactures, and distributes medical devices and equipment worldwide. The company offers peripheral interventional products, including Supercross PTA balloon dilatation catheters, Angiocide peripheral cutting balloons, and PeakSheath disposable artery sheath; and cardiovascular products, such as coronary stents and balloons, catheters, guide … Read more
Market Cap & Net Worth: Lepu Medical Tech Beijing (300003)
Lepu Medical Tech Beijing (SHE:300003) has a market capitalization of $4.57 Billion (CN¥33.49 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #4135 globally and #405 in its home market, demonstrating a 4.55% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lepu Medical Tech Beijing's stock price CN¥18.17 by its total outstanding shares 1843396544 (1.84 Billion).
Lepu Medical Tech Beijing Market Cap History: 2015 to 2026
Lepu Medical Tech Beijing's market capitalization history from 2015 to 2026. Data shows growth from $4.39 Billion to $4.57 Billion (1.05% CAGR).
Index Memberships
Lepu Medical Tech Beijing is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$644.79 Billion | 0.43% | #52 of 100 |
Weight: Lepu Medical Tech Beijing's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Lepu Medical Tech Beijing Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lepu Medical Tech Beijing's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.47x
Lepu Medical Tech Beijing's market cap is 0.47 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
11.54x
Lepu Medical Tech Beijing's market cap is 11.54 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.39 Billion | $2.77 Billion | $520.89 Million | 1.58x | 8.42x |
| 2016 | $4.09 Billion | $3.47 Billion | $679.26 Million | 1.18x | 6.03x |
| 2017 | $5.54 Billion | $4.54 Billion | $899.09 Million | 1.22x | 6.16x |
| 2018 | $4.79 Billion | $6.36 Billion | $1.22 Billion | 0.75x | 3.93x |
| 2019 | $7.67 Billion | $7.80 Billion | $1.73 Billion | 0.98x | 4.45x |
| 2020 | $6.34 Billion | $8.04 Billion | $1.80 Billion | 0.79x | 3.52x |
| 2021 | $5.32 Billion | $10.66 Billion | $1.72 Billion | 0.50x | 3.09x |
| 2022 | $5.48 Billion | $10.61 Billion | $2.20 Billion | 0.52x | 2.49x |
| 2023 | $3.91 Billion | $7.98 Billion | $1.26 Billion | 0.49x | 3.11x |
| 2024 | $2.85 Billion | $6.10 Billion | $246.94 Million | 0.47x | 11.54x |
Competitor Companies of 300003 by Market Capitalization
Companies near Lepu Medical Tech Beijing in the global market cap rankings as of March 19, 2026.
Key companies related to Lepu Medical Tech Beijing by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Lepu Medical Tech Beijing Historical Marketcap From 2015 to 2026
Between 2015 and today, Lepu Medical Tech Beijing's market cap moved from $4.39 Billion to $ 4.57 Billion, with a yearly change of 1.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥4.57 Billion | +14.93% |
| 2025 | CN¥3.97 Billion | +39.42% |
| 2024 | CN¥2.85 Billion | -27.17% |
| 2023 | CN¥3.91 Billion | -28.59% |
| 2022 | CN¥5.48 Billion | +3.04% |
| 2021 | CN¥5.32 Billion | -16.13% |
| 2020 | CN¥6.34 Billion | -17.37% |
| 2019 | CN¥7.67 Billion | +60.14% |
| 2018 | CN¥4.79 Billion | -13.55% |
| 2017 | CN¥5.54 Billion | +35.38% |
| 2016 | CN¥4.09 Billion | -6.69% |
| 2015 | CN¥4.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Lepu Medical Tech Beijing was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.57 Billion USD |
| MoneyControl | $4.57 Billion USD |
| MarketWatch | $4.57 Billion USD |
| marketcap.company | $4.57 Billion USD |
| Reuters | $4.57 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.